Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04167696
Title Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02 (CYCLE-1)
Acronym CYCLE-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celyad Oncology SA
Age Groups: adult | senior
Covered Countries USA | BEL

Facility Status City State Zip Country Details
Mayo Clinic Cancer Center NOT_YET_RECRUITING Jacksonville Florida 32224 United States Details
University of Kansas Cancer Center RECRUITING Fairway Kansas 66205 United States Details
Uz Leuven RECRUITING Leuven 3000 Belgium Details
Chu Liege RECRUITING Liège 4000 Belgium Details
AZ DELTA RECRUITING Roeselare 8800 Belgium Details
*Shaded cells indicate that there was no data available from for the field